MedTrace Logo

20- Versus 23- Gauge System for Pars Plana Vitrectomy

NCT00411970 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2007-10-25

No results posted yet for this study

Summary

The aim of the present study is to compare the functional and clinical differences and advantages between a standard operating system and a newly developed even smaller system for pars plana vitrectomy.

The present study may work out the possible advantages and disadvantages between the routinely used 20-gauge vitrectomy system and the newly developed 23-gauge device.

Conditions

Interventions

DEVICE

20- and 23 gauge vitreoretinal surgery systems

Sponsors & Collaborators

  • The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

    lead OTHER

Principal Investigators

  • Susanne Binder, Prof. MD · Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery

  • Lukas M Kellner, MD · Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery

  • Barbara Wimpissinger, MD · Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Completion
2007-10-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00411970 on ClinicalTrials.gov